1 1

Elipta (Linagliptin + Empagliflozin)

Elipta (Linagliptin + Empagliflozin)

Brand Name: Elipta
Origin: Bangladesh
Small Orders: Available
Tags: blood glucose control , Diabetes Medicine , DPP-4 inhibitor , Empagliflozin , Linagliptin , oral diabetes medicine , SGLT2 inhibitor , Type 2 Diabetes , Ziska Pharmaceuticals
Ver todos los detalles
  • Details
  • Description
Composition: Linagliptin + Empagliflozin
Treatment: Type 2 diabetes mellitus; helps improve blood glucose control
Form: Tablet
Brand: Elipta
Quantity Unit: Tablets
Manufacturer: Ziska Pharmaceuticals Ltd.

Elipta (Linagliptin + Empagliflozin) is an oral combination medicine used to help control blood sugar levels in adults with type 2 diabetes. Linagliptin helps increase insulin release when blood sugar is high, while Empagliflozin helps the kidneys remove excess glucose through urine. Together, they improve blood glucose control and may provide additional benefits for certain patients with type 2 diabetes.

Everyone Deserves Access to Life-saving Treatment Of Cancer. We are a Trusted Cancer Medicine seller delivering certified medications to every corner of the world.